USPTO Examiner RODRIGUEZ HOLLY MAE - Art Unit 2944

Recent Applications

Detailed information about the 100 most recent patent applications.

Application NumberTitleFiling DateDisposal DateDispositionTime (months)Office ActionsRestrictionsInterviewAppeal
30023331WARMERSeptember 2025November 2025Allow200NoNo
30023338WARMERSeptember 2025November 2025Allow200NoNo
30006937NETWORK DEVICEJune 2025October 2025Allow500NoNo
30002766SCALPELMay 2025November 2025Allow600NoNo
29993224Front Cover for Instruments for Medical UseMarch 2025December 2025Allow900NoNo
29976844RADIAL ARTERY ACCESS SUPPORTDecember 2024November 2025Allow1100NoNo
29975611SURGICAL ROBOT BODYNovember 2024December 2025Allow1200NoNo
29975615SURGICAL CAMERA ASSEMBLYNovember 2024December 2025Allow1200NoNo
29975621SURGICAL ROBOT BODYNovember 2024December 2025Allow1200NoNo
29972070FOETAL VACUUM EXTRACTOR HANDLENovember 2024November 2025Allow1200NoNo
29971716Endotracheal TubeNovember 2024November 2025Allow1200NoNo
29967771Cupping DeviceOctober 2024October 2025Allow1200NoNo
29966986SEALED FLUID CONTAINEROctober 2024October 2025Allow1200NoNo
29961513Beauty MaskSeptember 2024October 2025Allow1400NoNo
29957328COOLING THERAPY DEVICEAugust 2024September 2025Allow1300NoNo
35521402Portable fetal heart rate monitoring devicesMay 2024April 2025Allow1000NoNo
35521180Electronic muscle stimulator for medical purposesApril 2024January 2026Allow1900NoNo
29915297WARMEROctober 2023January 2026Allow2701NoNo
29914418APPARATUS FOR THERMOTHERAPYOctober 2023October 2025Allow2410NoNo
29904590Skin Treatment EquipmentOctober 2023November 2025Allow2510NoNo
29913409HEATING AND COOLING THERAPY DEVICE FOR A SHOULDERSeptember 2023October 2025Allow2510NoNo
29879851ELECTRONIC DEVICEJuly 2023October 2025Allow2700NoNo
35519335Suction device for use in manual therapyDecember 2022January 2026Allow2511NoNo
35519075Sauna cabinNovember 2022January 2026Allow3811NoNo
35518230Support for computer terminalsSeptember 2022October 2025Abandon3810NoNo
29791603TOOL FOR BODY TEMPERING AND TRIGGER POINTS HAVING INTERCHANGEABLE PARTSJanuary 2022September 2025Allow4401NoNo
29807746AURICULAR STIMULATION DEVICESeptember 2021November 2025Allow5011YesNo
29763987ABSORBENT ARTICLEDecember 2020January 2026Allow6011NoNo

Appeals Overview

No appeal data available for this record. This may indicate that no appeals have been filed or decided for applications in this dataset.

Examiner RODRIGUEZ, HOLLY MAE - Prosecution Strategy Guide

Executive Summary

Examiner RODRIGUEZ, HOLLY MAE works in Art Unit 2944 and has examined 2 patent applications in our dataset. With an allowance rate of 100.0%, this examiner allows applications at a higher rate than most examiners at the USPTO. Applications typically reach final disposition in approximately 10000 months.

Allowance Patterns

Examiner RODRIGUEZ, HOLLY MAE's allowance rate of 100.0% places them in the 98% percentile among all USPTO examiners. This examiner is more likely to allow applications than most examiners at the USPTO.

Office Action Patterns

On average, applications examined by RODRIGUEZ, HOLLY MAE receive 1.00 office actions before reaching final disposition. This places the examiner in the 9% percentile for office actions issued. This examiner issues significantly fewer office actions than most examiners.

Prosecution Timeline

The median time to disposition (half-life) for applications examined by RODRIGUEZ, HOLLY MAE is 10000 months. This places the examiner in the 0% percentile for prosecution speed. Applications take longer to reach final disposition with this examiner compared to most others.

Interview Effectiveness

Conducting an examiner interview provides a +0.0% benefit to allowance rate for applications examined by RODRIGUEZ, HOLLY MAE. This interview benefit is in the 16% percentile among all examiners. Note: Interviews show limited statistical benefit with this examiner compared to others, though they may still be valuable for clarifying issues.

Examiner Cooperation and Flexibility

Examiner's Amendments: This examiner makes examiner's amendments in 0.0% of allowed cases (in the 32% percentile). This examiner makes examiner's amendments less often than average. You may need to make most claim amendments yourself.

Quayle Actions: This examiner issues Ex Parte Quayle actions in 200.0% of allowed cases (in the 100% percentile). Per MPEP § 714.14, a Quayle action indicates that all claims are allowable but formal matters remain. This examiner frequently uses Quayle actions compared to other examiners, which is a positive indicator that once substantive issues are resolved, allowance follows quickly.

Prosecution Strategy Recommendations

Based on the statistical analysis of this examiner's prosecution patterns, here are tailored strategic recommendations:

  • Plan for extended prosecution: Applications take longer than average with this examiner. Factor this into your continuation strategy and client communications.

Relevant MPEP Sections for Prosecution Strategy

  • MPEP § 713.10: Examiner interviews - available before Notice of Allowance or transfer to PTAB
  • MPEP § 714.12: After-final amendments - may be entered "under justifiable circumstances"
  • MPEP § 1002.02(c): Petitionable matters to Technology Center Director
  • MPEP § 1004: Actions requiring primary examiner signature (allowances, final rejections, examiner's answers)
  • MPEP § 1207.01: Appeal conferences - mandatory for all appeals
  • MPEP § 1214.07: Reopening prosecution after appeal

Important Disclaimer

Not Legal Advice: The information provided in this report is for informational purposes only and does not constitute legal advice. You should consult with a qualified patent attorney or agent for advice specific to your situation.

No Guarantees: We do not provide any guarantees as to the accuracy, completeness, or timeliness of the statistics presented above. Patent prosecution statistics are derived from publicly available USPTO data and are subject to data quality limitations, processing errors, and changes in USPTO practices over time.

Limitation of Liability: Under no circumstances will IronCrow AI be liable for any outcome, decision, or action resulting from your reliance on the statistics, analysis, or recommendations presented in this report. Past prosecution patterns do not guarantee future results.

Use at Your Own Risk: While we strive to provide accurate and useful prosecution statistics, you should independently verify any information that is material to your prosecution strategy and use your professional judgment in all patent prosecution matters.